Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck
    Glisson, BS
    Murphy, BA
    Frenette, G
    Khuri, FR
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1593 - 1599
  • [22] Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma
    Mok, Tony
    Yang, Tsai-Shen
    Chao, Yee
    Wang, Cheng-Hsu
    Liu, Mei-Ching
    Kang, Yoon Koo
    Kang, Won Ki
    Kim, Jun Suk
    Wang, Yajie
    Leung, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 95 - 100
  • [23] Evaluation of safety and tolerability of durvalumab (D) and tremelimumab (T) in combination with first-line chemotherapy in patients (pts) with esophageal squamous-cell carcinoma (ESCC).
    Lee, Dae Ho
    Kim, HyeRyun
    Keam, Bhumsuk
    Kato, Ken
    Kuboki, Yasutoshi
    Vlahovic, Gordana
    Takahashi, Osamu
    Fitts, David
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
    Su Jin Lee
    Sungmin Kim
    Moonjin Kim
    Jeeyun Lee
    Yeon Hee Park
    Young-Hyuck Im
    Se Hoon Park
    BMC Cancer, 15
  • [25] Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
    Lee, Su Jin
    Kim, Sungmin
    Kim, Moonjin
    Lee, Jeeyun
    Park, Yeon Hee
    Im, Young-Hyuck
    Park, Se Hoon
    BMC CANCER, 2015, 15
  • [26] Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
    Xuyuan Li
    Wen Lin
    Hongbiao Wang
    Wenzhao Lin
    Suiling Lin
    Yingcheng Lin
    Medical Oncology, 2013, 30
  • [27] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Yu-Hong Li
    Feng-Hua Wang
    Wen-Qi Jiang
    Xiao-Juan Xiang
    Yan-Ming Deng
    Guo-Qing Hu
    De-Ming Xu
    Yan Chen
    Qing Lin
    You-Jian He
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 539 - 544
  • [28] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Li, Yu-Hong
    Wang, Feng-Hua
    Jiang, Wen-Qi
    Xiang, Xiao-Juan
    Deng, Yan-Ming
    Hu, Guo-Qing
    Xu, De-Ming
    Chen, Yan
    Lin, Qing
    He, You-Jian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 539 - 544
  • [29] Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
    Li, Xuyuan
    Lin, Wen
    Wang, Hongbiao
    Lin, Wenzhao
    Lin, Suiling
    Lin, Yingcheng
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [30] A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
    Jialei Wang
    Jianhua Chang
    Hui Yu
    Xianghua Wu
    Huijie Wang
    Wenhua Li
    Dongmei Ji
    Wei Peng
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 905 - 911
12345